GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

Trending Topics in Gastroenterology

Explore current gastroenterology questions, clinical answers, and emerging research by topic.

41

Rome V Anorectal Disorders: Gastroenterology | May 2026

The Rome V Anorectal Disorders chapter introduces several important revisions that substantially modernize the diagnostic and therapeutic approach to anorectal disorders within the disorders of gut–brain interaction (DGBI)...

42

Rome V Bowel Disorders: Gastroenterology | May 2026

The Rome V Bowel Disorders chapter is one of the most clinically relevant revisions in Rome V because it substantially updates the diagnostic framework for disorders of gut–brain...

43

Rome V Process: Gastroenterology | May 2026

The Rome V process represents the most rigorous methodological evolution in the history of the Rome Foundation and marks a major conceptual maturation in how disorders of gut–brain...

44

Rome V Pediatric Lower DGBI: Gastroenterology | May 2026

Rome V reframes pediatric lower gastrointestinal disorders of gut–brain interaction (DGBI) around symptom clusters and anatomic domains rather than age-based groupings, a clinically important shift that better reflects...

45

IBD with IBS-Like Symptoms (Rome Foundation & IOIBD Joint Consensus): Gastroenterology | May 2026

Introduction A significant number of patients with inflammatory bowel disease in remission continue to report symptoms such as abdominal pain, bloating, and altered bowel habits. These symptoms often...

46

Gastrointestinal Involvement in Scleroderma: Gastroenterology | May 2026

Summary Systemic sclerosis (SSc), the systemic form of scleroderma, is a multisystem disorder characterised by fibrosis, vasculopathy, and immune dysregulation. Gastrointestinal involvement is extremely common, affecting up to...

47

Antibiotic-Associated Diarrhea in ICU: JGH | March 2026

Introduction Antibiotic-associated diarrhea (AAD) is a frequent and clinically significant complication of antimicrobial therapy, particularly in critically ill patients. The pathogenesis primarily involves disruption of the gut microbiota,...

48

Probiotics in IBS: JGH | March 2026

Introduction Irritable bowel syndrome is a highly prevalent functional gastrointestinal disorder with significant impact on quality of life and healthcare costs. Despite multiple therapeutic options, management remains challenging...

49

Clostridioides difficile Infection: AMJ, March 2026

This review highlights that CDI management now requires both accurate diagnosis and a strategy to prevent recurrence. Diagnosis should not rely on a single test alone, because PCR...

50

IBS Pharmacotherapy Safety: AMJ, March 2026

Introduction Choosing drug therapy for irritable bowel syndrome (IBS) requires balancing symptom benefit against treatment-related adverse effects. While clinicians often use the number needed to treat (NNT) to...

Previous
145613
Next
GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer